Dishman Pharmaceuticals and Chemicals Ltd(Merged)

Dishman Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dishman Pharmaceuticals and Chemicals Ltd(Merged)

₹ 301 2.71%
29 May 2017
dishmangroup.com BSE: 532526 NSE: DISHMAN
About

Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 4,861 Cr.
  • Current Price ₹ 301
  • High / Low ₹ /
  • Stock P/E 77.8
  • Book Value ₹ 67.1
  • Dividend Yield 0.00 %
  • ROCE 12.6 %
  • ROE 9.97 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 19.1%

Cons

  • Stock is trading at 4.49 times its book value
  • The company has delivered a poor sales growth of 3.94% over past five years.
  • Company has a low return on equity of 9.43% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016
104 157 90 114 122 164 137 104 130 2 93 120 101
65 88 60 81 80 120 97 73 87 2 60 77 69
Operating Profit 40 69 30 32 42 44 40 31 43 0 33 43 32
OPM % 38% 44% 34% 29% 34% 27% 29% 29% 33% 22% 36% 36% 32%
3 46 4 25 6 31 9 50 3 0 5 25 6
Interest 15 12 15 16 22 15 26 19 14 0 16 10 7
Depreciation 12 10 15 7 11 11 11 11 11 0 11 11 11
Profit before tax 16 93 4 34 14 50 12 51 21 0 11 47 19
Tax % 34% 25% 60% 26% 44% 56% 35% 23% 19% 30% 20% 20% 15%
11 70 2 25 8 22 8 39 17 0 8 38 16
EPS in Rs 1.31 8.65 0.20 3.14 1.00 2.72 0.97 4.82 2.11 0.02 0.52 2.34 1.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 TTM
216 275 359 416 353 421 463 485 473 492 510 317
159 205 280 279 237 318 318 315 297 344 340 208
Operating Profit 57 70 79 137 116 103 145 169 176 148 171 109
OPM % 26% 25% 22% 33% 33% 24% 31% 35% 37% 30% 33% 34%
9 17 20 5 15 14 11 14 56 68 62 36
Interest 7 8 10 27 30 41 58 53 69 68 69 34
Depreciation 11 14 17 20 21 28 32 35 44 44 44 34
Profit before tax 48 65 73 95 80 49 68 95 119 104 120 77
Tax % 5% 6% 18% 3% 12% 17% 34% 33% 27% 44% 28%
46 61 60 92 71 40 45 63 87 58 87 62
EPS in Rs 8.43 7.47 11.42 8.81 4.97 5.56 7.83 10.75 7.25 10.80 3.88
Dividend Payout % 11% 12% 13% 11% 14% 24% 22% 15% 11% 28% 19%
Compounded Sales Growth
10 Years: 9%
5 Years: 4%
3 Years: 2%
TTM: -41%
Compounded Profit Growth
10 Years: 7%
5 Years: 17%
3 Years: 11%
TTM: -27%
Stock Price CAGR
10 Years: 9%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 9%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Equity Capital 14 14 16 16 16 16 16 16 16 16 16
Reserves 158 255 438 537 597 625 657 709 781 820 895
294 298 244 291 434 561 489 523 525 630 630
64 121 109 67 134 220 279 251 235 216 173
Total Liabilities 530 688 807 911 1,181 1,423 1,442 1,499 1,557 1,683 1,714
151 205 256 269 354 487 470 683 695 694 670
CWIP 37 49 111 173 268 199 257 49 10 10 22
Investments 12 131 133 156 182 187 187 187 187 210 251
329 303 308 313 377 550 527 581 665 769 772
Total Assets 530 688 807 911 1,181 1,423 1,442 1,499 1,557 1,683 1,714

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
10 21 42 91 110 118 250 28 126 15 125
-65 -194 -119 -101 -214 -191 -52 6 -48 -36 -30
177 54 76 8 105 73 -195 -30 -78 25 -102
Net Cash Flow 122 -119 -0 -1 1 0 2 4 -0 4 -8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Debtor Days 131 160 95 54 73 110 76 47 54 72 63
Inventory Days 292 265 236 243 259 215 223 260 278 293 274
Days Payable 119 109 90 48 195 206 159 194 174 170 143
Cash Conversion Cycle 303 316 240 249 137 119 140 113 158 196 193
Working Capital Days 237 248 216 231 276 138 106 196 198 280 341
ROCE % 14% 12% 16% 12% 8% 11% 12% 15% 12% 13%

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016Dec 2016Mar 2017
61.40% 61.40% 61.40% 61.40%
19.30% 15.75% 15.08% 10.92%
4.64% 7.26% 7.87% 9.92%
14.66% 15.59% 15.65% 17.76%
No. of Shareholders 47,78143,89952,29152,417

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls